Westbrook-based IDEXX Laboratories Inc. (Nasdaq: IDXX) on Friday morning reported revenue of $826 million during the year’s second quarter, an increase over the same period in 2020 of 30% on a reported basis and 26% organically.
IDEXX, which makes veterinary diagnostic tools and practice software as well as water microbiology tests, reported earnings per share of $2.34. That represented 36% growth as reported and 33% on a comparable basis, and exceeded the consensus estimate by Zacks Investment Research of $2.01. Read more
